Power Your H2 2025 Portfolio with Our Top 5 Partner Picks
At Farmak International, our purpose is simple yet ambitious: transform complex science into life-changing solutions.
As you look to grow and diversify your portfolio in the second half of 2025, our Top 5 Partner Recommendations demonstrate exactly why we’re the partner of choice for leading pharmaceutical companies worldwide.
Discover how each of these solutions highlights a different facet of our expertise and how they can power new opportunities in your market.
1 – Vasopressin/Argipressin – Hormone Expertise
Creating stable peptide-based drugs calls for both technical skill and impeccable cold-chain systems. With Vasopressin, Farmak International has proven its ability to develop and manufacture peptide medications that meet stringent quality, efficacy, and safety standards.
▶ Why it is special: complex aseptic manufacturing, robust process, and secure distribution channels.
▶ What it means for you: Confidence that we can manage every detail of specialized hormonal products.
Being one of the few companies in Europe to manufacture Vasopressin to this level of excellence showcases our dedication to continuous improvement and compliance with stringent international standards.
Dmytro Firsovsky Head of Regulatory Affairs, Farmak International
2 – Syndrex – High-Potency Vitamin Infusion
Handling multiple active ingredients in a sterile solution demands strong expertise, advanced formulation, and testing techniques—areas where Farmak International excels.
▶ Why it’s special: stringent aseptic processing, stability testing for multi-component solutions.
▶ What it means for you: A single 1+1 ampoule set replaces up to 11 separate conventional vitamin ampoules, significantly simplifying preparation and administration.
At Farmak International, we go beyond merely supplying high-quality products. We aim to build lasting partnerships by offering unparalleled customer service and innovative solutions.
Iryna Rozhnovska Senior Business Development Manager, Farmak International
3 – Carbetocin (thermostable) – Solution for Injection
Our thermostable Carbetocin removes cold-chain constraints, ensuring reliability from production to patient.
▶ Why it’s special: heat-stable formulation validated for ambient storage (≤ 25 °C) for up to 36 months; no refrigeration or thermal containers required; EU CTD dossier ready.B2B advantage: Cold-chain-free transport slashes logistics costs and enables straightforward distribution to rural or resource-limited markets.
▶ Clinical advantage: Immediate, at-hand use during postpartum-hemorrhage emergencies, no need to retrieve from a refrigerator or wait for the solution to warm to room temperature, saving critical seconds.
▶ What it means for you: Greater flexibility in supply chain management and expanded reach in settings without guaranteed refrigeration.
4 – Progesterone – Soft-Gel Capsules
Our Progesterone soft-gel capsules meet diverse clinical needs.
▶ Indications: amenorrhea; dysfunctional (anovulatory) uterine bleeding; endocrine infertility (including luteal-phase support); threatened miscarriage; oligomenorrhea; dysmenorrhea on a hypogonadism background.
▶ Why it’s special: capsules, oral/vaginal soft-gel (100 mg, 200 mg) with excipient-driven bioavailability for consistent therapeutic levels.
5 – Testosterone Undecanoate 1000 mg / 4 mL – Intramuscular Injection
Long-interval androgen replacement with a proven profile.
▶ Market context: despite Nebido® being the reference brand, there are very few generics on the market owing to the complexity of reproducing its long-acting oily formulation.
▶ Why it’s special: deep-IM vial presentation for dosing every 10–14 weeks, manufactured with a meticulously controlled oil-based vehicle (viscosity, solvent ratio, release profile) to mirror the originator’s pharmacokinetics.
▶ What it means for you: entry into a high-value niche with minimal generic competition; simplified treatment schedules that boost adherence; and an EU CTD dossier backed by completed long-term bioequivalence studies, saving you months and millions in development costs.
Beyond the Molecule: Comprehensive Services
These five recommendations underscore Farmak International’s end-to-end service model, combining:
• Contract Research & Development – from pilot studies to final formulation.
• Contract Manufacturing – flexible production for diverse dosage forms and volumes.
• Distribution & Out-Licensing – seamless global market expansion and brand-building.
Ready to Explore New Possibilities?
To see our complete portfolio, visit our Product List.
For more information or to schedule a conversation, reach out to bd@farmak.ch.
Farmak International – your go-to partner for complex generics and end-to-end market access.
Legal & Regulatory Notices
1) For Healthcare Professionals (HCPs) only. This material is intended solely for qualified healthcare professionals and related stakeholders and should not be shared with the general public.
2) Nebido® is a registered trademark of Bayer AG. Farmak International makes no claim of ownership and is not affiliated with the brand owner.
3) Medical information disclaimer. The content is provided for informational purposes only and does not constitute medical or legal advice; prescribing decisions must rely on locally approved product information.
4) Regulatory disclaimer. Product availability, indications, and labeling may vary by country and are subject to local regulatory approval.
5) Trademark disclaimer. All other product names and trademarks are the property of their respective owners.
